Richard Pzena Biogen Inc. Transaction History

Pzena Investment Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$275.25 - $318.06 $445,354 - $514,621	1,618 New	1,618 $460,000
Q1 2022 May 06, 2022	BUY	$193.77 - $244.14 $461,947 - $582,029	2,384 New	2,384 $502,000
Q4 2020 Feb 05, 2021	SELL	$236.26 - $355.63 $674,994 - $1.02 Million	-2,857 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$264.77 - $305.71 $102,201 - $118,004	-386 Reduced 11.9%	2,857 $810,000
Q2 2020 Jul 31, 2020	SELL	$258.66 - $342.55 $11.4 Million - $15 Million	-43,908 Reduced 93.12%	3,243 $868,000
Q1 2020 May 01, 2020	SELL	$268.85 - $341.04 $677,233 - $859,079	-2,519 Reduced 5.07%	47,151 $14.9 Million
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $10.2 Million - $14.1 Million	46,477 Added 1455.59%	49,670 $14.7 Million
Q3 2019 Nov 01, 2019	BUY	$217.44 - $243.88 $190,260 - $213,395	875 Added 37.75%	3,193 $743,000
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $29,165 - $32,148	-133 Reduced 5.43%	2,318 $542,000
Q1 2019 May 03, 2019	BUY	$216.71 - $338.96 $74,764 - $116,941	345 Added 16.38%	2,451 $579,000
Q4 2018 Feb 08, 2019	BUY	$278.5 - $352.75 $67,397 - $85,365	242 Added 12.98%	2,106 $634,000
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $21,719 - $28,403	74 Added 4.13%	1,864 $659,000
Q2 2018 Aug 03, 2018	BUY	$257.52 - $306.91 $11,073 - $13,197	43 Added 2.46%	1,790 $520,000
Q1 2018 May 04, 2018	BUY	$260.13 - $367.91 $212,266 - $300,214	816 Added 87.65%	1,747 $478,000
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $286,412 - $320,803	931	931 $297,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.